Here are six observations:
1. An increasing aging population as well as a growing demand for CTDR devices for degeneration disc disease will also spur market growth.
2. Market trends include technological advancemans, research and development investment and merger and acquisition activity.
3. The metal on biocompatible material segment accounts for the majority market share, and will likely continue leading the market. This is due to the materials’ greater rotation and flexibility.
4. In 2014, the hospitals segment led the CTDR device market in terms of end user.
5. However, the ambulatory surgery center segment is anticipated to grow at a higher compound annual growth rate than the hospital segment. This is because cervical disc replacement may be performed in ASCs, and more patients are choosing the outpatient setting.
6. Zimmer Biomet, Medtronic, Depuy Synthes, Globus Medical and NuVasive lead the market.
More articles on devices:
35 spine, orthopedic devices receive FD A 510(k) clearance in September 2016
SpineGuard reports €1.7M Q3 2016 revenue — 6 notes
5 observations on how 3D printing is transforming the medical device industry
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
